Recommendation to adopt the type 1C VWD nomenclature into the classification of von Willebrand disease: communication from the ISTH Scientific and Standardisation Subcommittee on von Willebrand Factor
Journal of Thrombosis and Haemostasis · 2026-07 · 24 (7) · 2656-2660
DOI: 10.1016/j.jtha.2026.02.010 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-07. Verfasst von Christopher J Ng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Colorado - Anschutz Medical Campus, Aurora, CO, USA. Electronic address: Christopher.ng@cuanschutz.edu. Hauptthemen laut MEDLINE: von Willebrand Factor, Terminology as Topic, von Willebrand Disease, Type 1, von Willebrand Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Health Resources and Services Administration, National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND: Von Willebrand disease (VWD) has 6 categories of either quantitative or qualitative abnormality of von Willebrand factor (VWF). As our understanding of the pathophysiology of VWD improves, there is a need to re-evaluate the classification system consistently. The International Society of Thrombosis and Haemostasis (ISTH) VWF Scientific and standardisation committee (SSC) sought endorsement from the ISTH membership to change the VWD classification to include type 1C VWD (increased VWF clearance) and Type 2M-P VWD (platelet binding defect) and Type 2M-C VWD (collagen binding defect). METHOD: After approval of the VWF SSC, the proposals and scientific justification for each VWD classification change were presented at the ISTH VWF SSC virtual 2020 Congress. This was followed by an online vote of the ISTH community promoted via the ISTH Congress, the VWF SSC mailing list, and social media. It was open from July 2020 to December 2020, with an a priori criteria of at least 75% approval to endorse the proposed subtypes. RESULTS: The inclusion of Type 1C VWD was confirmed with an approval of 94.2%. Although type 2M-P VWD and Type 2M-C VWD had merit, they did not meet the required threshold for approval (71.9%). CONCLUSION: There was an overwhelming endorsement for including Type 1C in the VWD classification, which occurs in around 20% of Type 1 VWD patients with a shortened VWF survival. Although generally supported, the threshold was not met to include the subcategorization of Type 2M-P VWD and Type 2M-C VWD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of Colorado - Anschutz Medical Campus, Aurora, CO, USA. Electronic address: Christopher.ng@cuanschutz.edu.
- Western Australia Centre for Thrombosis and Haemostasis, Murdoch University, Perth, Australia; Clinical Research Unit, Perth Blood Institute, Perth, Australia; Hollywood Hospital Haemophilia Centre, Haematology Academic…
- Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland; National Coagulation Centre, St James's Hospital, Dublin, Ireland.
- Blood Research Institute and Diagnostic Laboratories, Versiti, Milwaukee, Wisconsin, USA.
Förderung
- Health Resources and Services Administration
- National Institutes of Health
Zitieren
APA
Ng, C. J., Baker, R. I., Lavin, M., & Haberichter, S. L. (2026). Recommendation to adopt the type 1C VWD nomenclature into the classification of von Willebrand disease: communication from the ISTH Scientific and Standardisation Subcommittee on von Willebrand Factor. Journal of Thrombosis and Haemostasis, 24(7), 2656-2660. https://doi.org/10.1016/j.jtha.2026.02.010
Vancouver
Ng CJ, Baker RI, Lavin M, Haberichter SL. Recommendation to adopt the type 1C VWD nomenclature into the classification of von Willebrand disease: communication from the ISTH Scientific and Standardisation Subcommittee on von Willebrand Factor. Journal of Thrombosis and Haemostasis. 2026;24(7):2656-2660. doi:10.1016/j.jtha.2026.02.010
BibTeX
@article{Ng2026,
author = {Ng, Christopher J and Baker, Ross I and Lavin, Michelle and Haberichter, Sandra L},
title = {Recommendation to adopt the type 1C VWD nomenclature into the classification of von Willebrand disease: communication from the ISTH Scientific and Standardisation Subcommittee on von Willebrand Factor},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
volume = {24},
number = {7},
pages = {2656--2660},
doi = {10.1016/j.jtha.2026.02.010}
}
EUVIMED